The clinical outcomes and tolerability of adding radiotherapy to first-line chemoimmunotherapy for treating patients with metastatic or relapsed esophageal squamous cell carcinoma: A retrospective cohort study
When first-line CIT is used for patients with advanced ESCC, the addition of RT can improve patient prognosis while maintaining favorable safety profiles.
Authors
- Rui Duan (ORCID: https://orcid.org/0000-0001-5035-5633)
- Zhen Ren
- Xin Ding
- Xin Hou (ORCID: https://orcid.org/0000-0002-7785-0834)
Institutions
- Xuzhou Medical College (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-08-27
- DOI
- https://doi.org/10.12669/pjms.41.9.12491
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00